FdaApplication

ANDA 211097

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAPOTEX INC
application_typeANDA
approval_date2023-11-16

Products (1)

ProductActive ingredientStrengthDosage form
TERIPARATIDETERIPARATIDE0.56MG/2.24ML (0.25MG/ML)SOLUTION;SUBCUTANEOUS

1 product